Alimera Sciences, Inc. (ALIM): Price and Financial Metrics

Alimera Sciences, Inc. (ALIM)

Today's Latest Price: $4.74 USD

0.09 (1.94%)

Updated Nov 25 4:00pm

Add ALIM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

ALIM Stock Summary

  • ALIM has a market capitalization of $24,324,467 -- more than approximately merely 8.69% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for ALIM is -7.13 -- better than just 1.99% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -7.9 for Alimera Sciences Inc; that's greater than it is for just 2.19% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Alimera Sciences Inc are CMPR, MARK, NEOS, ADMS, and AQST.
  • ALIM's SEC filings can be seen here. And to visit Alimera Sciences Inc's official web site, go to

ALIM Stock Price Chart Interactive Chart >

Price chart for ALIM

ALIM Price/Volume Stats

Current price $4.74 52-week high $9.98
Prev. close $4.65 52-week low $2.86
Day low $4.63 Volume 23,100
Day high $4.76 Avg. volume 38,763
50-day MA $4.69 Dividend yield N/A
200-day MA $5.31 Market Cap 24.33M

ALIM Latest News Stream

Event/Time News Detail
Loading, please wait...

ALIM Latest Social Stream

Loading social stream, please wait...

View Full ALIM Social Stream

Latest ALIM News From Around the Web

Below are the latest news stories about Alimera Sciences Inc that investors may wish to consider to help them evaluate ALIM as an investment opportunity.

Alimera Sciences Inc (ALIM) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Alimera Sciences Inc (NASDAQ: ALIM)Q2 2020 Earnings CallJul 30, 2020, 1:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by.

Yahoo | July 31, 2020

Alimera (ALIM) to Report Q2 Earnings: What's in the Cards?

Alimera (ALIM) will provide updates on its corporate developments during the second-quarter 2020 earnings release.

Yahoo | July 23, 2020

Alimera Sciences to Report Second Quarter 2020 Financial Results on Wednesday, July 29, 2020 and Provide Corporate Update

Conference Call to be held Thursday, July 30, 2020 at 9:00 AM Eastern Time

GlobeNewswire | July 22, 2020

Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema

A randomized, controlled, multi-center study designed to demonstrate better disease control, reduced retinal damage and a reduction in treatment frequency compared to current.

Yahoo | July 9, 2020

New Strong Buy Stocks For June 25th

New Strong Buy Stocks For June 25th

Yahoo | June 25, 2020

Read More 'ALIM' Stories Here

ALIM Price Returns

1-mo 12.86%
3-mo -21.91%
6-mo -5.75%
1-year -15.05%
3-year -75.88%
5-year -90.19%
YTD -37.47%
2019 -29.62%
2018 -46.02%
2017 23.15%
2016 -55.37%
2015 -56.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7989 seconds.